HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Rapid Responses: Submit a response Alert me when this article is cited Alert me when Rapid Responses are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yawn, B. Articles by Knudtson, M. Search for Related Content PubMed PubMed Citation Articles by Yawn, B. Articles by Knudtson, M.

Treating Asthma and Comorbid Allergic Rhinitis in Pregnancy

Olmsted Medical Center, University of Minnesota, Rochester, MN (BY)
Department of Family Medicine, University of California at Irvine, Irvine, CA (MK)

Correspondence: Corresponding author: Barbara Yawn, MD, MSc, FAAFP, Director of Research, Research Department, Olmsted Medical Center, 210 Ninth Street Southeast, Rochester, MN 55904 (E-mail: yawnx002{at}umn.edu)

Women with severe or uncontrolled asthma are at higher risk for pregnancy complications and adverse fetal outcomes than women with well-controlled asthma. Recent evidence-based guidelines have concluded that it is safer for pregnant women with asthma to be treated pharmacologically than to continue to have asthma symptoms and exacerbations. According to the Asthma and Pregnancy Working Group (APWG) of the National Asthma Education and Prevention Program, optimal treatment of asthma during pregnancy includes treatment of comorbid allergic rhinitis (AR), which can trigger or aggravate asthma symptoms. In general, treatment of both asthma and AR during pregnancy should follow the same stepwise approach that is used in the general population. This article presents the specific recommendations from the most recent APWG report and from other systematic reviews about which asthma and allergic rhinitis drugs should be preferred during pregnancy. Of the corticosteroids, budesonide has the most data and is listed as Pregnancy Category B (no evidence of risk in humans). Other inhaled and intranasal corticosteroids have less data and are listed as Pregnancy Category C but may be continued during pregnancy if the patient's asthma was well controlled with the medication before pregnancy. Family physicians should help their patients control allergic rhinitis and asthma during pregnancy, encouraging adherence to needed medications.

This article has been cited by other articles:

				M. Enoz Re: Treating Asthma and Comorbid Allergic Rhinitis in Pregnancy J Am Board Fam Med, May 1, 2008; 21(3): 251 - 251. [Full Text] [PDF]